Profit Margin (Quarterly) Chart

View Profit Margin (Quarterly) for RVTY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Profit Margin (Quarterly) Chart
Start Trial

Historical Profit Margin (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 7.33%
March 31, 2026 5.75%
December 31, 2025 12.40%
September 30, 2025 6.76%
June 30, 2025 7.67%
March 31, 2025 6.27%
December 31, 2024 12.12%
September 30, 2024 13.65%
June 30, 2024 10.50%
March 31, 2024 4.42%
December 31, 2023 9.13%
September 30, 2023 4.84%
June 30, 2023 8.27%
March 31, 2023 3.68%
December 31, 2022 14.50%
September 30, 2022 9.77%
June 30, 2022 18.04%
March 31, 2022 19.11%
December 31, 2021 17.91%
September 30, 2021 12.50%
June 30, 2021 20.02%
March 31, 2021 29.01%
December 31, 2020 28.08%
September 30, 2020 18.33%
June 30, 2020 16.90%
Date Value
March 31, 2020 5.17%
December 31, 2019 8.01%
September 30, 2019 8.29%
June 30, 2019 9.57%
March 31, 2019 5.46%
December 31, 2018 9.43%
September 30, 2018 11.19%
June 30, 2018 9.19%
March 31, 2018 4.04%
December 31, 2017 -5.99%
September 30, 2017 17.42%
June 30, 2017 11.47%
March 31, 2017 7.01%
December 31, 2016 10.99%
September 30, 2016 10.48%
June 30, 2016 10.77%
March 31, 2016 8.38%
December 31, 2015 11.26%
September 30, 2015 9.74%
June 30, 2015 8.69%
March 31, 2015 7.65%
December 31, 2014 5.15%
September 30, 2014 7.91%
June 30, 2014 9.35%
March 31, 2014 6.45%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Agilent Technologies, Inc. 18.47%
Danaher Corp. 13.89%
Thermo Fisher Scientific, Inc. 14.52%
Waters Corp. -5.68%
Bio-Rad Laboratories, Inc. 57.05%